Paper7074794
Effects of verapamil and propranolol on left ventricular systolic function and diastolic filling in patients with coronary artery disease: radionuclide angiographic studies at rest and during exercise.
Bonow RO and 7 others. Circulation, 1982. Cited by 141 papers, by iCite.
Cite this record
ConductScience Library. Effects of verapamil and propranolol on left ventricular systolic function and diastolic filling in patients with coronary artery disease: radionuclide angiographic studies at rest and during exercise. Papers, record 7074794. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7074794
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Effects of verapamil and propranolol on left ventricular systolic function and diastolic filling in patients with coronary artery disease: radionuclide angiographic studies at rest and during exercise.
- PubMed
- Publication types
- Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Coronary Disease | Major topic |
| Myocardial Contraction | Major topic |
| Propranolol | Major topic |
| Verapamil | Major topic |
| Adult | |
| Blood Pressure | |
| Erythrocytes | |
| Female | |
| Heart | |
| Heart Rate | |
| Heart Ventricles | |
| Humans | |
| Male | |
| Middle Aged | |
| Physical Exertion | |
| Radionuclide Imaging | |
| Technetium |
Source PubMed
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 141 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40896250 | Sex-specific human electromechanical multiscale in-silico models for virtual therapy evaluation. | J Mol Cell Cardiol Plus | 2025 | https://conductscience.org/library/papers/40896250 | PubMed |
| 21803233 | Exercise intolerance. | Cardiol Clin | 2011 | https://conductscience.org/library/papers/21803233 | PubMed |
| 21110143 | Treatment of heart failure with normal ejection fraction. | Curr Treat Options Cardiovasc Med | 2011 | https://conductscience.org/library/papers/21110143 | PubMed |
| 18313628 | Exercise intolerance. | Heart Fail Clin | 2008 | https://conductscience.org/library/papers/18313628 | PubMed |
| 9926117 | Isolated diastolic heart failure--what is it? | Postgrad Med J | 1998 | https://conductscience.org/library/papers/9926117 | PubMed |
| 8011570 | Comparison of the efficacy of atenolol and its combination with slow-release nifedipine in chronic stable angina. | Cardiovasc Drugs Ther | 1993 | https://conductscience.org/library/papers/8011570 | PubMed |
| 6145515 | The clinical and hemodynamic effects of propranolol, pindolol and verapamil in the treatment of exertional angina pectoris. | Can Med Assoc J | 1984 | https://conductscience.org/library/papers/6145515 | PubMed |
| 3555566 | A double blind placebo controlled comparison of verapamil, atenolol, and their combination in patients with chronic stable angina pectoris. | Br Heart J | 1987 | https://conductscience.org/library/papers/3555566 | PubMed |
| 3154677 | Calcium channel antagonists. Part II: Use and comparative properties of the three prototypical calcium antagonists in ischemic heart disease, including recommendations based on an analysis of 41 trials. | Cardiovasc Drugs Ther | 1988 | https://conductscience.org/library/papers/3154677 | PubMed |
| 3123064 | Quantitative radionuclide angiocardiography. | Cardiovasc Intervent Radiol | 1987 | https://conductscience.org/library/papers/3123064 | PubMed |
| 2874975 | The haemodynamic effects of nifedipine, verapamil and diltiazem in patients with coronary artery disease. A review. | Drugs | 1986 | https://conductscience.org/library/papers/2874975 | PubMed |
| 2860122 | Direct and indirect effects of calcium entry blocking agents on isovolumic left ventricular relaxation in conscious dogs. | J Clin Invest | 1985 | https://conductscience.org/library/papers/2860122 | PubMed |
| 2670511 | Verapamil. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension. | Drugs | 1989 | https://conductscience.org/library/papers/2670511 | PubMed |
| 2577296 | Pharmacology of acute effort angina. | Cardiovasc Drugs Ther | 1989 | https://conductscience.org/library/papers/2577296 | PubMed |
| 2364959 | Phase analysis of radionuclide angiography in acute myocardial infarction. | Eur J Nucl Med | 1990 | https://conductscience.org/library/papers/2364959 | PubMed |
| 2083561 | Role of single photon wall motion and perfusion studies in the evaluation of patients with suspected coronary artery disease. | Eur J Nucl Med | 1990 | https://conductscience.org/library/papers/2083561 | PubMed |
| 2081143 | Effects of acute administration of gallopamil on left ventricular relaxation and filling dynamics in acute myocardial infarction assessed by Doppler echocardiography. | Cardiovasc Drugs Ther | 1990 | https://conductscience.org/library/papers/2081143 | PubMed |
| 1720378 | Calcium antagonists in patients with heart failure. A review. | Drugs | 1991 | https://conductscience.org/library/papers/1720378 | PubMed |
| 1463428 | Improvement of relaxation velocity parameters by calcium channel blockers in the aging rabbit myocardium. | Basic Res Cardiol | 1992 | https://conductscience.org/library/papers/1463428 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7074794
GET https://conductscience.org/api/papers/v1/7074794/authors